Globus Medical, Inc. (GMED)
Automate Your Wheel Strategy on GMED
With Tiblio's Option Bot, you can configure your own wheel strategy including GMED - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol GMED
- Rev/Share 18.3596
- Book/Share 29.8929
- PB 1.9192
- Debt/Equity 0.0226
- CurrentRatio 4.4453
- ROIC 0.0495
- MktCap 7766714572.0
- FreeCF/Share 3.7847
- PFCF 15.0056
- PE 42.2808
- Debt/Assets 0.0196
- DivYield 0
- ROE 0.0455
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 3
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | GMED | BTIG Research | Buy | Neutral | -- | -- | May 27, 2025 |
| Upgrade | GMED | BofA Securities | Underperform | Neutral | -- | $97 | Jan. 10, 2025 |
News
GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?
Published: March 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Globus Medical's robust musculoskeletal offerings and synergies from the NuVasive merger are fueling its stock gains.
Read More
New Product Launches Benefit GMED Stock Amid Macro Issues
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Globus Medical currently awaits a strong cadence of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.
Read More
Globus Medical, Inc. (GMED) Q4 2024 Earnings Call Transcript
Published: February 20, 2025 by: Seeking Alpha
Sentiment: Neutral
Globus Medical, Inc. (NYSE:GMED ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development and IR Daniel Scavilla - President and CEO Keith Pfeil - COO and CFO Conference Call Participants Vik Chopra - Wells Fargo Matt Miksic - Barclays David Saxon - Needham & Company Jason Wittes - ROTH Shagun Singh - RBC Caitlin Cronin - Canaccord Genuity Craig Bijou - Bank of America Securities Matthew O'Brien - Piper Sandler Steve Lichtman - Oppenheimer Ryan Zimmerman - BTIG Matthew Blackman - Stifel Operator Welcome to the Globus Medical's Fourth …
Read More
Globus Medical (GMED) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Globus Medical (GMED) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Globus Medical (GMED) Q4 Earnings and Revenues Top Estimates
Published: February 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Globus Medical (GMED) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.60 per share a year ago.
Read More
Globus Medical: Q4 Revenue Tops Forecast
Published: February 20, 2025 by: The Motley Fool
Sentiment: Positive
Medical technologies specialist Globus Medical (GMED 0.04%) reported impressive results for the fourth quarter of 2024 on Thursday, Feb. 20. The highlights included adjusted earnings per share (EPS) of $0.84, exceeding the consensus forecast of $0.75, along with revenue that reached $657.3 million, topping expectations by $12.3 million.
Read More
About Globus Medical, Inc. (GMED)
- IPO Date 2012-08-03
- Website https://www.globusmedical.com
- Industry Medical - Devices
- CEO Mr. Daniel T. Scavilla
- Employees 5300